No Data
Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024
This Biodesix Insider Increased Their Holding In The Last Year
Lake Street Maintains Biodesix(BDSX.US) With Buy Rating, Maintains Target Price $3
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Biodesix (BDSX) and CVRx (CVRX)
Biodesix Named to Inc. Magazine's 2024 "Best Workplaces"
Biodesix to Participate in Two Investor Conferences in June
The Dark Night :![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
White_Shadow :![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)